Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
4
Lantheus
LNTH
5
Hutchmed (China)
HCM
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.77%37.29M | -2.09%149.56M | -0.54%37.29M | 2.16%38.61M | -1.00%37.39M | -8.60%36.64M | 2.98%152.75M | -7.45%37.49M | -2.43%37.79M | 6.45%37.77M |
Net interest income | 2.91%28.87M | -3.26%113.84M | 0.95%29.07M | -0.78%28.96M | -3.58%27.76M | -9.22%28.06M | 3.51%117.68M | -12.63%28.79M | -2.42%29.19M | 8.56%28.79M |
-Net interest income | 3.44%47.4M | 8.35%188.72M | 3.64%47.48M | 7.63%48.58M | 9.23%46.84M | 13.56%45.82M | 37.66%174.18M | 20.07%45.82M | 36.42%45.14M | 48.95%42.88M |
-Interest income from loans and lease | 5.91%41.8M | 9.65%163.85M | 5.49%41.7M | 9.45%42.04M | 10.07%40.63M | 14.21%39.47M | 38.61%149.42M | 21.24%39.53M | 37.48%38.41M | 50.19%36.92M |
-Interest income from securities | -11.90%5.6M | 0.47%24.88M | -7.97%5.78M | -2.75%6.54M | 4.02%6.2M | 9.70%6.35M | 32.21%24.76M | 13.20%6.28M | 30.67%6.72M | 41.76%5.96M |
-Total interest expense | 4.29%18.53M | 32.52%74.89M | 8.19%18.42M | 23.03%19.62M | 35.40%19.08M | 88.12%17.77M | 339.91%56.51M | 227.22%17.02M | 402.33%15.95M | 521.02%14.09M |
-Interest expense for deposit | 6.74%15.51M | 61.37%61.7M | 25.06%16.21M | 41.69%16.17M | 72.06%14.78M | 176.01%14.53M | 420.59%38.23M | 310.32%12.96M | 533.81%11.42M | 618.83%8.59M |
-Interest expense for long term debt and capital securities | -6.71%3.02M | -27.83%13.19M | -45.67%2.21M | -23.95%3.45M | -21.85%4.3M | -22.58%3.24M | 232.21%18.28M | 98.73%4.06M | 229.99%4.53M | 412.20%5.5M |
Non interest income | -1.95%8.42M | 1.84%35.72M | -5.46%8.22M | 12.15%9.65M | 7.27%9.63M | -6.51%8.59M | 1.23%35.07M | 15.12%8.7M | -2.45%8.61M | 0.21%8.98M |
-Total premiums earned | 9.45%614K | -14.64%2.3M | 10.69%590K | 10.68%570K | 15.90%583K | -51.13%561K | 34.95%2.7M | 6.81%533K | 3.83%515K | -0.20%503K |
-Fees and commissions | 3.40%7.9M | 5.14%32.63M | 2.63%7.91M | 9.35%8.6M | 6.67%8.49M | 1.68%7.64M | 0.30%31.04M | 5.89%7.71M | 2.13%7.86M | -0.20%7.96M |
-Other non interest income | -49.74%195K | 8.96%973K | 30.16%397K | 18.28%220K | -21.28%344K | 8.08%388K | -33.36%893K | 195.31%305K | -64.64%186K | 25.94%437K |
-Gain loss on sale of assets | ---424K | -143.57%-193K | -547.68%-676K | 516.28%265K | 162.65%218K | --0 | 22.04%443K | 55.67%151K | -57.84%43K | -39.42%83K |
-Dividend income | --137K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Credit losses provision | 225.96%131K | 93.62%-180K | 253.16%922K | 66.12%-228K | 26.42%-585K | 83.31%-104K | 39.45%-2.82M | 75.38%-602K | 48.47%-673K | -48.88%-795K |
Non interest expense | 2.21%24.4M | 4.97%96.93M | 3.52%24.59M | 8.61%24.77M | 3.55%24.27M | 4.35%23.87M | 4.29%92.34M | 6.91%23.75M | -0.84%22.81M | 8.04%23.43M |
Occupancy and equipment | -25.67%3.33M | 3.00%13.79M | 332.43%480K | -0.36%4.45M | -0.23%4.38M | 1.34%4.47M | 0.78%13.39M | 282.76%111K | 0.25%4.47M | 0.43%4.39M |
Professional expense and contract services expense | 48.00%592K | -10.34%1.42M | -7.05%343K | 1.15%441K | -32.96%238K | -6.10%400K | -1.61%1.59M | -24.69%369K | 3.56%436K | -32.77%355K |
Selling and administrative expenses | 6.46%14.71M | 4.85%58.67M | -0.51%15.66M | 11.10%14.82M | 4.98%14.38M | 4.82%13.82M | 9.21%55.96M | 9.83%15.74M | 4.52%13.34M | 16.72%13.7M |
-General and administrative expense | 7.10%14.19M | 4.42%56.66M | -0.58%15.17M | 10.54%14.38M | 4.82%13.86M | 3.74%13.25M | 9.23%54.26M | 9.59%15.25M | 6.28%13.01M | 16.32%13.22M |
-Selling and marketing expense | -8.64%518K | 18.75%2.01M | 1.44%492K | 33.13%434K | 9.45%521K | 38.63%567K | 8.65%1.7M | 18.00%485K | -37.07%326K | 29.00%476K |
Depreciation amortization depletion | 450.21%1.28M | -0.04%5.13M | -0.05%4.43M | 0.00%233K | 0.00%233K | 0.00%233K | -1.80%5.13M | -2.08%4.43M | 0.00%233K | 0.00%233K |
-Depreciation and amortization | 450.21%1.28M | -0.04%5.13M | -0.05%4.43M | 0.00%233K | 0.00%233K | 0.00%233K | -1.80%5.13M | -2.08%4.43M | 0.00%233K | 0.00%233K |
Other non-interest expense | -9.24%4.49M | 10.06%17.93M | 18.52%3.68M | 11.42%4.83M | 5.85%5.03M | 7.10%4.95M | -5.25%16.29M | 9.14%3.1M | -15.52%4.33M | -1.35%4.75M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -6,480.00%-329K | 136.99%172K | 86.95%-71K | 0 | 188.37%248K | 28.57%-5K | -68.48%-465K | -3,726.67%-544K | 0 | 960.00%86K |
Less:Restructuring and mergern&acquisition | 1,095.00%239K | -92.93%20K | --0 | --0 | ---- | 0.00%20K | 6.39%283K | 392.22%263K | --0 | ---- |
Less:Other special charges | 700.00%90K | -205.49%-192K | -74.73%71K | ---- | -188.37%-248K | -15.38%-15K | 1,720.00%182K | 274.67%281K | ---- | -960.00%-86K |
Other non-operating income (expenses) | ||||||||||
Income before tax | 0.24%12.7M | -7.88%52.61M | 7.63%13.55M | -4.90%13.61M | -6.16%12.79M | -23.66%12.66M | 4.14%57.12M | -20.62%12.59M | -0.58%14.31M | 2.88%13.63M |
Income tax | -3.31%2.48M | -26.05%9.07M | -3.52%2.55M | -55.80%1.42M | -10.75%2.53M | -28.16%2.57M | 8.66%12.27M | -21.03%2.64M | 8.20%3.21M | 3.43%2.84M |
Earnings from equity interest net of tax | ||||||||||
Net income | 1.15%10.21M | -2.92%43.54M | 10.60%11M | 9.81%12.19M | -4.95%10.26M | -22.42%10.1M | 2.97%44.85M | -20.52%9.95M | -2.85%11.1M | 2.74%10.79M |
Net Income continuous operations | 1.15%10.21M | -2.92%43.54M | 10.60%11M | 9.81%12.19M | -4.95%10.26M | -22.42%10.1M | 2.97%44.85M | -20.52%9.95M | -2.85%11.1M | 2.74%10.79M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 1.15%10.21M | -2.92%43.54M | 10.60%11M | 9.81%12.19M | -4.95%10.26M | -22.42%10.1M | 2.97%44.85M | -20.52%9.95M | -2.85%11.1M | 2.74%10.79M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 1.15%10.21M | -2.92%43.54M | 10.60%11M | 9.81%12.19M | -4.95%10.26M | -22.42%10.1M | 2.97%44.85M | -20.52%9.95M | -2.85%11.1M | 2.74%10.79M |
Basic earnings per share | 1.52%0.67 | -3.38%2.86 | 9.09%0.72 | 9.59%0.8 | -5.63%0.67 | -23.26%0.66 | 2.07%2.96 | -20.48%0.66 | -3.95%0.73 | 1.43%0.71 |
Diluted earnings per share | 0.00%0.66 | -3.73%2.84 | 10.77%0.72 | 9.59%0.8 | -5.63%0.67 | -23.26%0.66 | 2.43%2.95 | -21.69%0.65 | -3.95%0.73 | 1.43%0.71 |
Dividend per share | 7.14%0.3 | 7.27%1.18 | 7.14%0.3 | 7.14%0.3 | 7.14%0.3 | 7.69%0.28 | 7.84%1.1 | 7.69%0.28 | 7.69%0.28 | 7.69%0.28 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |